These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38412735)

  • 61. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome.
    Walitt B; Singh K; LaMunion SR; Hallett M; Jacobson S; Chen K; Enose-Akahata Y; Apps R; Barb JJ; Bedard P; Brychta RJ; Buckley AW; Burbelo PD; Calco B; Cathay B; Chen L; Chigurupati S; Chen J; Cheung F; Chin LMK; Coleman BW; Courville AB; Deming MS; Drinkard B; Feng LR; Ferrucci L; Gabel SA; Gavin A; Goldstein DS; Hassanzadeh S; Horan SC; Horovitz SG; Johnson KR; Govan AJ; Knutson KM; Kreskow JD; Levin M; Lyons JJ; Madian N; Malik N; Mammen AL; McCulloch JA; McGurrin PM; Milner JD; Moaddel R; Mueller GA; Mukherjee A; Muñoz-Braceras S; Norato G; Pak K; Pinal-Fernandez I; Popa T; Reoma LB; Sack MN; Safavi F; Saligan LN; Sellers BA; Sinclair S; Smith B; Snow J; Solin S; Stussman BJ; Trinchieri G; Turner SA; Vetter CS; Vial F; Vizioli C; Williams A; Yang SB; ; Nath A
    Nat Commun; 2024 Feb; 15(1):907. PubMed ID: 38383456
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.
    Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG
    Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
    Daniels J; Brigden A; Kacorova A
    Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Eaton-Fitch N; Du Preez S; Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    J Transl Med; 2022 Feb; 20(1):94. PubMed ID: 35172836
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
    Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
    Front Immunol; 2021; 12():656797. PubMed ID: 34867935
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    Front Immunol; 2019; 10():2545. PubMed ID: 31736966
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Mensah FFK; Armstrong CW; Reddy V; Bansal AS; Berkovitz S; Leandro MJ; Cambridge G
    Front Immunol; 2018; 9():2421. PubMed ID: 30405620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome.
    Rasa-Dzelzkaleja S; Krumina A; Capenko S; Nora-Krukle Z; Gravelsina S; Vilmane A; Ievina L; Shoenfeld Y; Murovska M;
    J Transl Med; 2023 Jan; 21(1):33. PubMed ID: 36653846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis.
    Escorihuela RM; Capdevila L; Castro JR; Zaragozà MC; Maurel S; Alegre J; Castro-Marrero J
    J Transl Med; 2020 Jan; 18(1):4. PubMed ID: 31906988
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accurate and objective determination of myalgic encephalomyelitis/chronic fatigue syndrome disease severity with a wearable sensor.
    Palombo T; Campos A; Vernon SD; Roundy S
    J Transl Med; 2020 Nov; 18(1):423. PubMed ID: 33168001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
    J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
    Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
    Corbitt M; Eaton-Fitch N; Staines D; Cabanas H; Marshall-Gradisnik S
    BMC Neurol; 2019 Aug; 19(1):207. PubMed ID: 31445522
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP
    Eaton-Fitch N; Cabanas H; du Preez S; Staines D; Marshall-Gradisnik S
    J Transl Med; 2021 Jul; 19(1):306. PubMed ID: 34266470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis.
    Kerr JR; Petty R; Burke B; Gough J; Fear D; Sinclair LI; Mattey DL; Richards SC; Montgomery J; Baldwin DA; Kellam P; Harrison TJ; Griffin GE; Main J; Enlander D; Nutt DJ; Holgate ST
    J Infect Dis; 2008 Apr; 197(8):1171-84. PubMed ID: 18462164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.
    Almenar-Pérez E; Ovejero T; Sánchez-Fito T; Espejo JA; Nathanson L; Oltra E
    Clin Ther; 2019 Apr; 41(4):675-698. PubMed ID: 30910331
    [TBL] [Abstract][Full Text] [Related]  

  • 78. How do women with chronic fatigue syndrome/myalgic encephalomyelitis rate quality and coordination of healthcare services? A cross-sectional study.
    Hansen AH; Lian OS
    BMJ Open; 2016 Apr; 6(4):e010277. PubMed ID: 27044578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.
    Mueller C; Lin JC; Sheriff S; Maudsley AA; Younger JW
    Brain Imaging Behav; 2020 Apr; 14(2):562-572. PubMed ID: 30617782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.